BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27817804)

  • 1. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported physician-diagnosed chronic obstructive pulmonary disease and spirometry patterns in Vietnam Era US Army Chemical Corps veterans: A retrospective cohort study.
    Cypel YS; Hines SE; Davey VJ; Eber SM; Schneiderman AI
    Am J Ind Med; 2018 Oct; 61(10):802-814. PubMed ID: 30159906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.
    Samukawa T; Matsumoto K; Tsukuya G; Koriyama C; Fukuyama S; Uchida A; Mizuno K; Miyahara H; Kiyohara Y; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1469-1481. PubMed ID: 28553099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.
    Tsukuya G; Samukawa T; Matsumoto K; Fukuyama S; Kumamoto T; Uchida A; Koriyama C; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1903-9. PubMed ID: 27574414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Three Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Primary Care.
    Spyratos D; Haidich AB; Chloros D; Michalopoulou D; Sichletidis L
    Respiration; 2017; 93(2):83-89. PubMed ID: 28052294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of the lower limit of normal of FEV
    Liu S; Zhou Y; Liu S; Zou W; Li X; Li C; Deng Z; Zheng J; Li B; Ran P
    Respir Med; 2018 Jun; 139():27-33. PubMed ID: 29857998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
    Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
    COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).
    Hanania NA; Mannino DM; Yawn BP; Mapel DW; Martinez FJ; Donohue JF; Kosinski M; Rendas-Baum R; Mintz M; Samuels S; Jhingran P; Dalal AA
    Respir Med; 2010 Aug; 104(8):1160-70. PubMed ID: 20226647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameter D: New Measure of Airflow Obstruction.
    Bhatt SP; Nakhmani A; Thimmegowda NM; Sthanam V; Wilson CG; Bhakta NR; Kim YI; Bodduluri S
    Ann Am Thorac Soc; 2023 Jul; 20(7):993-1002. PubMed ID: 36989246
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.
    Tsukuya G; Matsumoto K; Fukuyama S; Crawford B; Nakanishi Y; Ichinose M; Machida K; Samukawa T; Ninomiya T; Kiyohara Y; Inoue H;
    Allergol Int; 2015 Jan; 64(1):49-53. PubMed ID: 25572558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterans Airflow Obstruction Screening Questionnaire: A Survey to Identify Veterans with Airflow Obstruction.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Chronic Obstr Pulm Dis; 2016 Aug; 3(4):705-715. PubMed ID: 28848897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.
    Lundgren FL; Cabral MM; Clímaco DC; de Macedo LG; Coelho Mde A; Dias AL
    J Bras Pneumol; 2007; 33(2):148-51. PubMed ID: 17724533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.
    Miller MR; Haroon S; Jordan RE; Sitch AJ; Dickens AP; Enocson A; Fitzmaurice DA; Adab P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1979-1986. PubMed ID: 29950827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.